-
California: Bills Expanding Marijuana Rights for Patients, Employees Advanced to Governor’s Desk
Lawmakers have advanced two bills to the desk of Democratic Gov. Gavin Newsom that seek to expand the rights of cannabis consumers. Senate Bill 302 expands existing law (The Compassionate Access to Medical Cannabis Act a/k/a Ryan’s Law) so that older patients suffering from chronic diseases may legally access certain cannabis products in private hospitals…
-
It’s ‘Go Time’ for Cannabis Bills in Congress
In the coming days, members of the House and Senate could take action on multiple important federal cannabis bills. The House Oversight Committee will be holding a markup hearing on the CURE Act this Wednesday. The legislation prevents people from being denied federal employment or security clearances solely due to cannabis use and allows those…
-
Reactions to the Rescheduling of Marijuana
While it is far from being official, it looks pretty clear that the Biden Administration’s plan is to reschedule marijuana as a Schedule III controlled substance in the ranks of steroids and ketamine. While that will be a mostly good sign for many businesses dealing with heightened Schedule I related taxes, there are also lots…
-
North Carolina: Tribal Voters Approve Measure to Allow for Eventual Sales of Marijuana to Adults
Members of North Carolina’s Eastern Band of Cherokee Indians have decided in favor of a referendum permitting the use and sale of marijuana on tribal land. According to preliminary results, 70 percent of voters backed the measure, which read: “Do you support legalizing the possession and use of cannabis for persons who are at least…
-
35 Years Ago Today: DEA’s Chief Administrative Law Judge Ruled That Cannabis Should Be Reclassified Under Federal Law
Today marks the 35-year anniversary of an administrative ruling by the US Drug Enforcement Administration’s (DEA) Chief Administrative Law Judge determining that cannabis possesses accepted medical utility in the United States and, therefore, it ought to be available to qualified patients. The ruling, issued on September 6, 1988 by DEA Judge Francis Young In the…
-
Desantis Reconfirms He Would Not Legalize Marijuana
In a recent presidential campaign event in Iowa, Ron DeSantis reaffirmed his opposition to the legalization of marijuana. He expressed concerns about the potential accessibility of cannabis to young children and the risk of it being adulterated with dangerous substances like fentanyl. According to DeSantis, the increasing potency of modern cannabis is a significant issue,…
-
New Study Shows Some Cannabis users May Have Elevated Levels of Lead and Cadmium
A recent study conducted by researchers at Columbia University has revealed that some marijuana users may have elevated levels of two heavy metals, lead and cadmium, in their blood and urine, raising concerns about potential long-term health issues associated with exposure to these contaminants. The study, published in the journal Environmental Health Perspectives, examined data…
-
Here’s what the deal is with Marijuana moving to Schedule III
Bloomberg News just got a huge scoop: a letter sent from the Department of Health and Human Services to the DEA recommending that marijuana be moved from Schedule I to Schedule III in the list of Controlled Substances. There has been a lot of reaction to this move – some very good and some very…
-
Report: Leaked HHS Letter Calls Upon DEA to Reschedule Cannabis
Bloomberg news has obtained a letter from a “top” Department of Health and Human Services (HHS) official recommending that the US Drug Enforcement Administration reclassify cannabis from a Schedule I to a Schedule III controlled substance under federal law. The letter, dated August 29th, comes ten months after the Biden administration requested “the Secretary of…
-
Analysis: Many ‘Hemp-Derived’ Delta-9 THC Products Sold Over the Counter Contain Synthetically Derived THC
A significant percentage of so-called ‘hemp-derived’ delta-9-THC products sold over the counter contain synthetically derived THC, according to data published in the Journal of Cannabis Research. Researchers performed laboratory analyses on 53 products marketed as containing “hemp-derived delta-9 tetrahydrocannabinol.” They reported that more than one-quarter of the products contained THC that had been naturally…